Huons Global Co., Ltd.

KOSDAQ 084110.KQ

Huons Global Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -48.74 M

Huons Global Co., Ltd. Net Cash Used For Investing Activities is USD -48.74 M for the year ending December 31, 2023, a -5,671.80% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Huons Global Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -844.46 K, a 93.02% change year over year.
Huons Global Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -12.10 M, a 92.27% change year over year.
Huons Global Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -156.44 M, a -224.26% change year over year.
Huons Global Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -48.24 M, a 15.01% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

KOSDAQ: 084110.KQ

Huons Global Co., Ltd.

CEO	Sooyoung Song
IPO Date	Dec. 19, 2006
Location	South Korea
Headquarters	253C-902 Pangyo-ro
Employees	122
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Cosmetics Dental Care Drugstores & Retail Pharmacies Personal Care Plastics

Description

Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and others, as well as circulatory, respiratory, and other tissue cell systems. It also provides medical devices, eye drop products, and bio products. The company was formerly known as Huons Co., Ltd. and changed its name to Huons Global Co., Ltd. in June 2016. Huons Global Co., Ltd. was founded in 1965 and is headquartered in Seongnam, South Korea.

Key trends

Past 5 years